Avanish Vellanki, Rain Oncology CEO
October 16, 2023 07:33 AM EDTUpdated 12:38 PM
Deals

Tang Cap­i­tal con­tin­ues biotech buy­ing spree with ac­qui­si­tion bid for Rain On­col­o­gy

Ayisha Sharma

News Reporter

Cal­i­for­nia in­vest­ment group Tang Cap­i­tal Man­age­ment has made its third takeover bid of the year for a strug­gling biotech, this time aimed at US com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times